apremilast
chemical compound
Facts
15 properties- Instance of
- type of chemical entity
- Subclass of
- (+/-)-apremilast
- Has use
- medication
- Active ingredient in
- Otezla
- Canonical SMILES
- CCOC1=C(C=CC(=C1)C(CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC
- Chemical formula
- C₂₂H₂₄N₂O₇S
- Defined daily dose
- 60 mg
- Isomeric SMILES
- CCOC1=C(C=CC(=C1)[C@@H](CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC
- LiverTox likelihood score
- LiverTox toxicity likelihood category E
- Mass
- 460.13 Da
- Medical condition treated
- osteoarthritis susceptibility 1, ankylosing spondylitis, psoriasis-related juvenile idiopathic arthritis, arthritis, Behçet's disease, guttate psoriasis, multiple sclerosis, psoriasis (2014–present), psoriatic arthritis (2014–present)
- Pregnancy category
- Australian pregnancy category B3, US pregnancy category C
- Subject has role
- non-steroidal anti-inflammatory drug
- World Health Organisation international non-proprietary name
- apremilast
🏷️ Also known as
en N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide
en Otezla®
en apremilast
en Apremilast
en Aprémilast
en Apremilastum
en CC 10004
en CC-10004
en CC10004
ar أبريميلاست
el απρεμιλάστη
fa اپرمیلست
he אפרמילסט
ja アプレミラスト
ru апремиласт
uk апреміласт
zh 阿普密蘭特
🔖 Identifiers · 33
- OpenAlex ID
- C2781427535
- ATC code
- L04AA32
- CAS Registry Number
- 608141-41-9
- ChEBI ID
- 78540
- ChEMBL ID
- CHEMBL514800
- ChemSpider ID
- 9736448
- DSSTOX compound identifier
- DTXCID601403667
- DSSTox substance ID
- DTXSID30976289
- DrugBank ID
- DB05676
- DrugCentral ID
- 4829
- EC number
- 807-237-6
- ECHA Substance Infocard ID
- 100.234.786
Show all 33 identifiers +21
- Freebase ID
- /m/052vhw8
- Guide to Pharmacology Ligand ID
- 7372
- HSDB ID
- 8221
- InChIKey
- IMOZEMNVLZVGJZ-QGZVFWFLSA-N
- KEGG ID
- D08860
- LiverTox ID
- Apremilast
- MeSH descriptor ID
- C505730
- MedlinePlus drug identifier
- a614022
- Microsoft Academic ID (discontinued)
- 2781427535
- NDF-RT ID
- N0000190644
- PDB ligand ID
- A9L
- Probes And Drugs ID
- PD009329
- PubChem CID
- 11561674
- Reaxys registry number
- 12446985
- RxNorm CUI
- 1492727
- SureChEMBL ID
- 302992
- UNII
- UP7QBP99PN
- UniChem compound ID
- 506404
- WikiProjectMed ID
- Apremilast
🔗 Connections
← Drug or therapy used for treatment 8
Medical condition treated 7
Has use 1
Subject has role 1
Press Enter · cited answer in seconds
0 sources
Summary
apremilast is a type of chemical entity[1]. apremilast is a type of (+/-)-apremilast[2].
Key Facts
- Canonical SMILES: CCOC1=C(C=CC(=C1)C(CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC[3]
- Chemical formula: C₂₂H₂₄N₂O₇S[4]
- Has use: medication[5]
- Has part(s): nitrogen[6], oxygen[7], carbon[8]
- Isomeric SMILES: CCOC1=C(C=CC(=C1)C@@HN2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OCC@@HN2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC">[9]
- Mass: 460.13 dalton[10]
- Medical condition treated: osteoarthritis susceptibility 1[11], ankylosing spondylitis[12], psoriasis-related juvenile idiopathic arthritis[13], arthritis[14], Behçet's disease[15], guttate psoriasis[16], multiple sclerosis[17], psoriasis[18], psoriatic arthritis[19]
- World Health Organisation international non-proprietary name: apremilast[20]
- Subject has role: non-steroidal anti-inflammatory drug[21]
- Pregnancy category: Australian pregnancy category B3[22], US pregnancy category C[23]
- Active ingredient in: Otezla[24]
- Defined daily dose: 60 milligram[25]
- LiverTox likelihood score: LiverTox toxicity likelihood category E[26]